- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07368829
AI-Driven Autonomous Registration in Robotic Bronchoscopy
April 9, 2026 updated by: Hecheng Li M.D., Ph.D, Ruijin Hospital
Feasibility and Safety of Artificial Intelligence-Driven Autonomous Registration in Robotic Navigational Bronchoscopy
This study aims to evaluate the feasibility and safety of an artificial intelligence (AI)-driven autonomous registration technology in robotic navigational bronchoscopy.
A total of 20 patients with pulmonary nodules requiring localization will be enrolled.
The Langhe Bronchoscopy Robot System equipped with AI-based autonomous registration software will be used.
Primary outcomes include the success rate of autonomous registration and the rate of manual intervention during the process.
Secondary outcomes encompass registration time, complication rates, and nodule localization success.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hecheng Li, M.D., Ph.D.
- Phone Number: +021 64370045
- Email: lihecheng2000@hotmail.com
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200025
- Recruiting
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
-
Contact:
- Hecheng Li
- Phone Number: +021 64370045
- Email: lihecheng2000@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥ 18 years.
- Radiologically confirmed pulmonary nodules requiring preoperative localization.
- Scheduled for robotic navigational bronchoscopy using the Bronchoscopy Robot System.
- Willing to provide written informed consent.
Exclusion Criteria:
- Severe cardiopulmonary dysfunction (e.g., FEV1 < 30% predicted).
- Coagulopathy or anticoagulation therapy that cannot be safely interrupted.
- Pregnancy or lactation.
- Inability to tolerate bronchoscopy under general anesthesia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Autonomous registration group
All participants in this arm will undergo robotic navigational bronchoscopy and pulmonary nodule localization performed using the Langhe Bronchoscopy Robot System.
The key intervention is the use of artificial intelligence (AI)-driven autonomous registration technology to automatically align the pre-operative chest CT images with the real-time bronchoscopic anatomy prior to the procedure.
This process aims to reduce reliance on the conventional, operator-dependent manual registration.
Physicians will supervise the entire process and perform necessary manual intervention if the AI registration is unsatisfactory or for safety reasons.
|
All participants in this arm will undergo robotic navigational bronchoscopy and pulmonary nodule localization performed using the Langhe Bronchoscopy Robot System.
The key intervention is the use of artificial intelligence (AI)-driven autonomous registration technology to automatically align the pre-operative chest CT images with the real-time bronchoscopic anatomy prior to the procedure.
This process aims to reduce reliance on the conventional, operator-dependent manual registration.
Physicians will supervise the entire process and perform necessary manual intervention if the AI registration is unsatisfactory or for safety reasons.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Autonomous registration success rate
Time Frame: Intraoperative
|
Proportion of registrations completed independently by the AI algorithm without manual intervention.
|
Intraoperative
|
|
Manual intervention rate during autonomous registration
Time Frame: Intraoperative
|
The proportion of cases requiring manual adjustment by the physician during the registration process.
|
Intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time consumed for autonomous registration
Time Frame: Intraoperative
|
Intraoperative
|
|
|
Complication rate during autonomous registration
Time Frame: Immediate post-procedure to 24 hours
|
Complication rate during autonomous registration (e.g., bleeding, pneumothorax)
|
Immediate post-procedure to 24 hours
|
|
Localization success rate of pulmonary nodules
Time Frame: Intraoperative
|
The proportion of successful bronchoscope arrivals at the target nodule after registration.
|
Intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
January 20, 2026
First Submitted That Met QC Criteria
January 20, 2026
First Posted (Actual)
January 27, 2026
Study Record Updates
Last Update Posted (Actual)
April 13, 2026
Last Update Submitted That Met QC Criteria
April 9, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- RTS-030
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchoscopy
-
University of ZurichRecruitingBronchoscopy | Propofol | Bronchoscopy Biopsy | Lung Lesions | Robotic Assisted BronchoscopySwitzerland
-
Paion UK Ltd.Premier Research Group plcCompleted
-
Guangzhou Institute of Respiratory DiseaseCompleted
-
Instituto de Investigación Sanitaria de la Fundación...Ambu A/SCompleted
-
MaineHealthCompleted
-
Pulmonx CorporationCompleted
-
Olympus Europe SE & Co. KGHeidelberg University; Lung Clinic HemerNot yet recruiting
-
American University of Beirut Medical CenterCompleted
-
Chang Gung Memorial HospitalCompleted
-
Pusan National University HospitalUnknownBronchoscopyKorea, Republic of
Clinical Trials on AI-driven autonomous registration
-
National and Kapodistrian University of AthensNot yet recruitingRestoration Design | Digital Occlusal CollisionGreece
-
Ain Shams UniversityActive, not recruiting
-
Deliberate Solutions Inc.Baylor College of MedicineRecruitingAnxiety Disorders | Depression DisordersUnited States
-
Alexandria UniversityCompleted
-
Turku University HospitalUnknownArtificial Intelligence | Triage
-
Johns Hopkins UniversityJuvenile Diabetes Research Foundation; National Eye Institute (NEI)RecruitingType 1 Diabetes | Type 2 Diabetes | Cystic Fibrosis-related DiabetesUnited States
-
Johns Hopkins UniversityNational Eye Institute (NEI)CompletedType 1 Diabetes | Type 2 DiabetesUnited States
-
University of California, San DiegoCompletedHypertensionUnited States
-
National Defense Medical Center, TaiwanRecruiting